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The mechanisms of hantavirus-induced modulation of host cellular immunity remain poorly understood.
Recently, microRNAs (miRNAs) have emerged as a class of essential regulators of host immune response
genes. To ascertain if differential host miRNA expression toward representative hantavirus species
correlated with immune response genes, miRNA expression proﬁles were analyzed in human endothelial
cells, macrophages and epithelial cells infected with pathogenic and nonpathogenic rodent- and shrew-
borne hantaviruses. Distinct miRNA expression proﬁles were observed in a cell type- and viral species-
speciﬁc pattern. A subset of miRNAs, including miR-151-5p and miR-1973, were differentially expressed
between Hantaan virus and Prospect Hill virus. Pathway analyses conﬁrmed that the targets of selected
miRNAs were associated with inﬂammatory responses and innate immune receptor-mediated signaling
pathways. Our data suggest that differential immune responses following hantavirus infection may be
regulated in part by cellular miRNA through dysregulation of genes critical to the inﬂammatory process.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Hantaviruses (genus Hantavirus), unlike other members of the
family Bunyaviridae, have no known arthropod vector, and instead
are hosted by small mammals, which are persistently infected.
Hantavirus diseases in humans, known as hemorrhagic fever with
renal syndrome (HFRS) and hantavirus cardiopulmonary syn-
drome (HCPS), are characterized by increased vascular perme-
ability. Hantaan virus (HTNV), Dobrava virus (DOBV), Seoul virus
(SEOV) and Puumala virus (PUUV) are the principal HFRS-causing
hantaviruses, whereas Sin Nombre virus (SNV) and Andes virus
(ANDV) are prototypic hantaviruses that cause HCPS. Prospect Hill
virus (PHV) and Tula virus (TULV) represent two of the many
putatively nonpathogenic rodent-borne hantaviruses (Easterbrook
and Klein, 2008; Klein and Calisher, 2007).
Thottapalayam virus (TPMV), initially an unclassiﬁed virus isolated
from the Asian house shrew (Suncus murinus) (Carey et al., 1971), is
now known to be among the most genetically and phylogenetically
divergent of all hantaviruses (Song et al., 2007a). Phylogenetic analysis
of Imjin virus (MJNV), recently isolated from the Ussuri white-toothed
shrew (Crocidura lasiura) (Song et al., 2009), and other newly
identiﬁed hantaviruses in shrews (Arai et al., 2007, 2008a, 2012;
Kang et al., 2011a, 2011b; Song et al., 2007a, 2007b; Song et al., 2009),
moles (Arai et al., 2008b; Kang et al., 2009a, 2009b, 2011a) and
insectivorous bats (Sumibcay et al., 2012; Weiss et al., 2012) indicates
an ancient origin and early evolutionary divergence from rodent-
borne hantaviruses.
Most hantaviruses are nonpathogenic, with only a limited
number of rodent-borne hantavirus species causing disease in
humans. Currently, the pathogenicity of the newly identiﬁed
hantaviruses harbored by shrews, moles and bats is unknown.
Previously, Gavrilovskaya et al. (1998) demonstrated that patho-
genic and nonpathogenic hantaviruses use β3 and β1 integrins,
respectively, to enter endothelial cells. Moreover, usage and
regulation of β3 integrins by HFRS- and HCPS-causing pathogenic
hantaviruses, compared to nonpathogenic hantaviruses, appear to
contribute to pathogenesis (Gavrilovskaya et al., 2002)
Recently, cellular miRNAs have been implicated in various viral
infections and are known to play a key role in the regulation of
cellular gene expression (Gottwein and Cullen, 2008; Skalsky and
Cullen, 2010). Studies indicate that ANDV infection of human
endothelial cells results in altered level of speciﬁc miRNAs, and
these miRNAs regulate angiogenesis and vascular integrity (Pepini
et al., 2010). Although endothelial cells are considered to be the
principal targets for hantaviruses, various other cell types, such as
macrophages and epithelial cells, have also been used to study the
pathogenicity of hantaviruses (Shim et al., 2011; Shin et al., 2012).
In the absence of known diseases or clinical syndromes
associated with non-rodent-borne hantaviruses, we attempted to
gain insights into their pathogenic potential by assessing the cell
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type- and virus species-speciﬁc changes in cellular miRNA signa-
tures in human endothelial, epithelial and macrophage cells
experimentally infected with two rodent-borne hantaviruses
(pathogenic HTNV and nonpathogenic PHV) and two shrew-
borne hantaviruses (putatively nonpathogenic TPMV and MJNV
of unknown pathogenicity). We identiﬁed a group of miRNAs
whose expression patterns differentiated the host response to
pathogenic vs. nonpathogenic hantaviruses. Our work provides a
global view of cell type- and viral species-speciﬁc miRNA proﬁles
and a target map of miRNAs, which is expected to contribute to
future investigations of miRNA regulatory mechanisms in the
pathogenesis of hantavirus infection and disease.
Results
Unique cellular miRNA expression proﬁling
To assess the host cellular miRNA expression in response to
hantavirus infection, three cell types (known to be susceptible to
hantaviruses) were infected with four hantavirus species. Among
1205 miRNAs present on the arrays, 319 miRNAs were reliably
expressed (excluding all the raw data values less than 10). The
global expression patterns of differentially expressed miRNAs
between HTNV, MJNV, TPMV and PHV-infected cells relative to a
mock control are shown by hierarchical clustering analysis in
Fig. 1. Global expression changes in miRNAs occurred depending
on the cell type. Notably, the number of differentially expressed
miRNAs, showing greater than 2-fold changes, was higher in
human umbilical vein endothelial cells (HUVEC), regardless of
viral species, compared to A549 or THP-1 cells. Thus, our data
suggest that distinct miRNA expression patterns are observed in a
cell type-speciﬁc manner in response to hantavirus infection.
Viral species- and cell type-speciﬁc miRNA expression proﬁling
changes
The number of differentially expressed miRNAs was compared
in cells infected with HTNV, MJNV, TPMV and PHV (shown as Venn
diagrams in Fig. 2). Only miRNAs that were altered at least 2-fold
were considered signiﬁcant candidates. Using these strict criteria,
26 up-regulated and 16 down-regulated miRNAs were identiﬁed
in HTNV-infected HUVEC, compared to 1 up-regulated and no
down-regulated miRNA in PHV-infected HUVEC (Fig. 2C and D).
Similarly, increased numbers of up- or down-regulated miRNAs
were identiﬁed in A549 and THP-1 cells infected with HTNV,
compared to PHV. For example, in A549 cells, there were 5 up-
regulated and 6 down-regulated miRNAs with HTNV, and 0 up-
regulated and 1 down-regulated miRNA with PHV, whereas in
THP-1 cells, there were 16 up-regulated and 4 down-regulated
miRNAs with HTNV, and no up- or down-regulated miRNAs with
PHV. In general, a limited number of miRNAs were detected in
PHV-infected cells. The numbers of miRNAs that showed down-
regulation in all virus samples was similar to the numbers of up-
regulated miRNAs.
One up-regulated and 3 down-regulated miRNAs from HUVEC
showed overlapping expression for HTNV, MJNV, TPMV and PHV.
The Venn diagrams showed no miRNAs that were common in
THP-1 cells infected with all four hantavirus species. In A549 cells,
16 up-regulated vs. 0 down-regulated miRNAs showing overlap-
ping expression were detected (Fig. 3). No overlapping expression
of miRNAs was detected with different cell types, suggesting cell
type-speciﬁc host responses after hantavirus infection. Thus, the
data indicate that infections with pathogenic and nonpathogenic
hantaviruses induce distinct cellular miRNA expression patterns in
different cells.
Distinct miRNA expression proﬁling between HTNV and PHV
Quantitative RT-PCR was performed to validate miRNA micro-
array analysis. Among several cellular miRNAs showing distinct
expression patterns between HTNV and PHV, we focused on four
miRNAs (miR-494, miR-642b-3p, miR-151a-5p, and miR-1973).
These miRNAs had different expression patterns between HTNV
and PHV, including directly opposite regulation (up in one and
down in the other) or regulation in the same direction but to
differing degrees (Fig. 4). For example, miR-1973 and miR-151a-5p
were up-regulated 2-fold and 42-fold, respectively, HTNV-
infected HUVEC, while no increased expression in these miRNA
was detected during PHV infection. In contrast, in THP-1 cells,
these miRNAs tended to be more highly expressed during HTNV
than PHV infection, while the expression of miR-494 and miR-
642b-3p did not differ between HTNV and PHV. Taken together,
the expression levels of several miRNAs were found to be opposite
in HTNV- and PHV-infected HUVEC and THP-1 cells.
Predicted targets of miRNAs affected by hantavirus infection
To fully inspect the function of the differentially expressed
miRNAs, we selected several miRNAs differentially expressed
between samples and analyzed predicted mRNA targets, using
GO term and KEGG pathway annotation. We decided to focus on
previously characterized or potentially important receptor and
signaling pathways regulated by pathogenic hantaviruses in cells
(Gavrilovskaya et al., 1999, 2008; Handke et al., 2009; Lee et al.,
2011). The following receptor and signaling pathways were
included for analysis: vascular endothelial growth factor (VEGF),
chemokine signaling pathway, innate immune receptors (integrin,
retinoic acid inducible gene-I (RIG-I)-like receptor (RLR),
nucleotide-binding oligomerization domain-containing protein
(NOD)-like receptor (NLR), Toll-like receptor (TLR) signaling path-
way)), inﬂammatory signaling pathways, including Janus kinase
(JAK)-signal transducer and activator of transcription (STAT),
phosphoinositide 3-kinase (PI3K)-Akt, mitogen activated protein
kinase (MAPK). Many of the selected miRNAs whose expression
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Fig. 1. Hierarchical clustering analysis showing viral species-speciﬁc regulation of
miRNAs during hantavirus infection. A549, HUVEC and THP-1 cells were infected
with HTNV, MJNV, TPMV or PHV (MOI of 0.5) or mock infected. RNA was collected
at day 3 post-infection. Heat maps depicting the miRNAs that are differentially
expressed in A549, HUVEC and THP-1 cells after infection are shown. Colors
indicate log2 ratios of infected vs. mock-infected control, according to the speciﬁed
scale. Red denotes up-regulation, while green indicates down-regulation, high-
lighting signiﬁcantly deregulated miRNAs at the corresponding viral infection.
Clustering program: MeV 4.7.1 was used; Clustering method: Euclidean distance,
average linkage, gene tree.
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was opposite between HTNV and PHV infection were shown to
have mRNA targets involved in innate immune signaling receptors
and inﬂammatory signaling pathways (Table 1). These pathways
were also found to be regulated by reliably expressed miRNAs by
ingenuity pathway analysis (IPA) (Fig. S1).
To further characterize the function of differentially expressed
miRNAs, IPA was used to generate gene lists known to have direct
or indirect functional relationships with these miRNAs. There was
a signiﬁcant enrichment of genes involved in immune cell trafﬁck-
ing, cell-mediated immune response, and inﬂammatory response
(Fig.S2). The interaction of miRNAs which were differentially
expressed (either up-regulated or down-regulated only in HTNV
or PHV) between HTNV and PHV was analyzed for four mRNA
genes: myxovirus resistance gene A (MxA), interferon-β (IFN-β
interferon gamma-induced protein-10 (IP-10), and Regulated upon
Activation, Normal T-cell Expressed, and Secreted (RANTES). These
genes were selected based on our previous results, which sug-
gested differential expression of these genes in response to HTNV,
compared to PHV (Shin et al., 2012). Furthermore, in addition to
mRNA levels, IP-10 protein expression levels in hantavirus-
infected cell supernatants were conﬁrmed in Fig. S3. In HUVEC,
two miRNAs (miR-3132 and miR-146a-5p) were found to target
these genes (Fig. 5). miR-3132 was only up-regulated in PHV and
unchanged in HTNV, while miR-146a-5p was only up-regulated in
HTNV and unchanged in PHV. miR-3132 targets CXCL-10 (IP-10),
whereas miR-146a-5p targets CCL5 (RANTES) and IFN-β. Our data
suggest an inverse relationship between these miRNAs and their
targets in that up-regulation of miR-3132 in PHV led to less
production of CXCL-10 in comparison to HTNV. Similarly, increased
expression of miR-146a-5p led to less expression of IFN-β in HTNV,
compared to PHV. Furthermore, the interaction of miRNAs which
were differentially expressed between HTNV-infected HUVEC,
A549 cells or THP-1 cells also revealed an inverse relationship
between these miRNAs and their target mRNA genes. miR-3652,
miR-3656 and miR-4271 were down-regulated in HUVEC and their
target CCL5 was highly up-regulated in HUVEC. Also, miR-15b-5p
was down-regulated in A549 and its target CXCL-10 was up-
regulated in these cells (Fig. 6A). Similarly, miR-503 was down-
regulated in THP-1 cells and its targets CCL5 and CXCL-10 were
highly up-regulated in THP-1 cells, as compared to HUVEC
(Fig. 6B). Therefore, our network analysis supports the miRNA
and mRNA expression data of anti-viral and inﬂammatory mole-
cules differentially induced by these hantaviruses.
Discussion
Host miRNAs appear to play critical roles in virus–host inter-
actions. Host miRNA proﬁling has been well described for several
viruses, including hepatitis C virus (HCV) (Murakami et al., 2006),
human immunodeﬁciency virus type 1 (HIV-1) (Gupta et al., 2011,
2012), inﬂuenza viruses (Loveday et al., 2012), human T-cell
Fig. 2. Venn diagrams of overlapping miRNA proﬁles for different cell types. The miRNA differential expression in HTNV, MJNV, TPMV and PHV is depicted in four
overlapping circles for 2-fold up-regulation and 2-fold down-regulation for (A and B) A549, (C and D) HUVEC, and (E and F) THP-1. The numbers indicate the miRNA counts
in the indicated area.
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lymphotropic virus type I (HTLV-I) (Ruggero et al., 2010; Sampey
et al., 2012) and human cytomegalovirus (HCMV) (Li et al., 2011).
In contrast, the involvement of miRNAs during hantavirus infec-
tion is largely unexplored. Here, we provide experimental
evidence demonstrating the complex cell type- and virus
species-speciﬁc regulation of host miRNAs by pathogenic and
nonpathogenic hantaviruses in different human cells. We found
that several miRNAs were differentially expressed between patho-
genic HTNV and putatively nonpathogenic PHV and that these
miRNAs were found to have targets associated with innate
immune receptor signaling and inﬂammatory pathways.
Because the differential pathogenicity between rodent-borne
and shrew-borne hantaviruses may stem from differences in host
miRNA expression, we decided to analyze hantaviral species-
speciﬁc patterns of host miRNA expression. Increased number of
differentially expressed miRNAs in cells infected with HTNV was
detected by hierarchical clustering heat map than in PHV-infected
cells. The down-regulation of miRNAs was more pronounced with
the highly pathogenic HTNV than with the nonpathogenic PHV.
Increased numbers of miRNAs unique to HUVEC were found to be
signiﬁcantly up- or down-regulated, compared with miRNAs
unique to A549 or THP-1 cells, indicating the cell type-speciﬁc
changes in miRNA expression proﬁling.
Our previous study showed that all the studied hantaviruses
replicated best in HUVEC and less productively in THP-1 and A549
cells (Shin et al., 2012). More distinct changes in miRNA expression
in HUVEC may result from higher kinetics and efﬁciency of viral
replication. It is possible that differences in hantavirus replication
and expression of viral proteins could contribute to differences in
miRNA expression that may be more related to how robust the
infection is rather than the particular virus–cell type combination.
Our previous data also indicate that HTNV and MJNV replicated
more efﬁciently in HUVEC and THP-1 cells, compared to PHV and
TPMV, and also caused the highest induction of anti-viral and pro-
inﬂammatory responses.
Our miRNA–mRNA interaction network supports our previous
ﬁndings in that differential expression pattern of mRNAs (such
as anti-viral responsive genes and pro-inﬂammatory genes) is
regulated by miRNAs oppositely expressed in HTNV vs. PHV. Up-
regulation of miR-3132 in PHV caused less expression of CXCL-10
in comparison to HTNV. Similarly, increased expression of miR-
146a-5p decreased expression of IFN-β in HTNV in comparison to
PHV. Differential induction of anti-viral and pro-inﬂammatory
responses between HTNV and PHV has been previously reported
and our data suggest that this regulation may be mediated by
speciﬁc miRNAs (Handke et al., 2009; Shim et al., 2011; Shin et al.,
2012). miR-146a is probably one of the most characterized miRNAs
so far, and it is known to negatively regulate signal transduction
pathways leading to NF-κB activation and thus, its dysregulation
is associated with diseases, such as cancer, viral infections and
Fig. 3. Venn diagrams of overlapping miRNA proﬁles for different hantaviruses. The
miRNAs differentially expressed in A549, HUVECs and THP-1 cells are depicted in
three overlapping circles for 2-fold up-regulation and 2-fold down-regulation,
respectively, for (A and B) HTNV, (C and D) MJNV, (E and F) TPMV and (G and H)
PHV. The numbers indicate the miRNA counts in the indicated area.
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Fig. 4. qRT-PCR analysis of miRNA expression during hantavirus infection. The
results of qRT-PCR analyses for (A) HUVEC and (B) THP-1 cells are shown. A total of
four miRNA expressions were determined, including miR-151-5p, miR-642b-3p,
miR-494 and miR-1973, after HTNV, MJNV, TPMV and PHV infection, respectively.
Each graph represents the mean absolute fold change of triplicate experiments for
each miRNA compared to mock-infected controls collected at day 3 post-infection.
All qRT-PCR data are represented as means7the SEM.
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Table 1
Biological pathways associated with targets of miRNAs differentially expressed in hantavirus infection. Differential expression of miRNAs during hantavirus infection was subjected to target prediction and pathway enrichment
analyses. All pathways were obtained from the KEGG and target analysis was performed using Tarbase, TargetScan, miRanda, microRNA.org and microcosm.
miRNA Integrin
signaling
pathway
Chemokine
signaling
pathway
RIG-I-like
receptor
signaling
pathway
NOD-like
receptor
signaling
pathway
Toll-like
receptor
signaling
pathway
Jak-STAT signaling
pathway
PI3K-Akt signaling pathway VEGF
signaling
pathway
MAPK signaling pathway
miR-494 FZD3, DNAJC,
MYNN, APLN
STAT1, GNG10,
RAP1B, PAK1,
IKBKB, MAP2K1
IKBKB, IL12B IKBKB IKBKB, IL12B,
STAT1, MAP2K1,
TLR6
IL12B, STAT1, IL6ST,
IL5RA, STAM, IL26,
SOCS5, SOCS4, MYC
IKBKB, GNG10, MAP2K1, FGFR2, CDK6,
CDK4, MYC, IGF1R
MAP2K1,
PTGS2
IKBKB, RAP1B, PAK1, MAP2K1, FGFR2,
IL1R1, PPM1A, MAP4K4, IL1A, JUND,
MYC, STK3
miR-1225-5p NR1H4 IFNG
miR-642-3p ASB2, C12orf4 CYLD, CASP10 MAP2K6 CBL, IL11 FLT1, LPAR4, SYK, ANGPT1, ITGB8 PPM1A, PAK2, MAP2K6
miR-151a-5p NTRK2
miR-29c-3p PCDHA10,
YPEL2
CDC42 DDX3X IGF1, SGK1, CDK2, LAMC1 CDC42 CDC42
miR-1973 IL8 IL8 IL8 IL8 CACNB1
miR-210 CACNA1C
miR-3656 PXN PXN
miR-1915-3p KCNC1,
VAMP1
ADCY1, FOXO3,
GSK3B
MAVS, IKBKE IKBKE, IRAK1,
MYD88
SOCS7, PTPN6,
IL20RB, IL2RB
FOXO3, GSK3B, PDGFRB, BCL2, FLT4, SYK,
IL2RB, FGFR3
SRF, PDGFRB, CACNG2, CACNG1, FGFR3
miR-1268a TOLLIP
miR-199a-5p ATP9A,
ZNF563
GSK3B DDX3X IL13 GSK3B, CDKN1B TGFB2,
MAP3K11,
STK4
miR-193a-3p ST6GALNAC3,
PLAU
OSMR OSMR, MCL1, LAMC2 STMN1, CACNA1E, NF1
miR-1207-5p 41531, SBNO1 CX3CL1, SRC CASP10 RIPK2 MAP2K6, TLR6 STAT6, CBL, IL6ST CHAD, CSF1, LAMC3, FLT1, CHRM1, PDPK1,
ITGB3
SRC,
MAPKAPK2
MAPKAPK2, CACNA2D1, MAP2K6,
JUND, TGFBR2, TGFBR1, CACNG7,
PPM1B, CACNB3, RAPGEF2, MAPK8IP3
miR-222-3p CBWD2,
MEGF9
JAK3 CYLD, AZI2 FOS JAK3, PRLR JAK3, KIT, CDKN1B, KDR, MDM2, PRLR KDR NTF3, CACNB4, NLK, STMN1, FOS
miR-181b-5p SPP1, ITGA2,
ITGB8, GP5
KRAS, RAP1B,
NRAS, GNB4,
MAP2K1
DDX3X, ATG5 CARD8 MAP2K1, SPP1,
TLR4, MAP2K4,
MAP3K8, IRF5
IL2, LIFR, CSF2RB,
PRLR, SOCS4
KRAS, NRAS, GNB4, MAP2K1, CREB1, SPP1,
ITGA2, IL2, CREB5, PRLR, FLT1, PDGFRA,
KITLG, TLR4, ITGB8, SGK3, DDIT4
KRAS, N
RAS,
MAP2K1,
PTGS2
KRAS, RAP1B, NRAS, MAP2K1, TGFBR1,
PDGFRA, IL1A, ZAK, MAP2K4, GNA12,
MAP3K8, CACNA2D4, MAP3K3
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autoimmune diseases (Labbaye and Testa, 2012; Ma et al., 2011;
Taganov et al., 2006).
MJNV and TPMV are representative shrew-borne hantaviruses
of unknown pathogenicity in humans. We previously reported that
shrew-borne hantaviruses differentially induce anti-viral and pro-
inﬂammatory innate immune responses, compared with non-
pathogenic PHV (Shin et al., 2012). We showed that TPMV and
PHV replicated less efﬁciently than HTNV and MJNV in both
HUVEC and THP-1 cells and this differential viral replication
pattern may explain the differential innate immune responses
triggered by differentially expressed miRNAs by each of these
viruses. Thus, this may affect expression of miRNAs involved in the
regulation of anti-viral and pro-inﬂammatory pathways. Our
current data with miRNA expression proﬁling indicate that
restricted numbers of miRNAs were changed in TPMV-infected
cells, compared with HTNV-infected cells. This supports the notion
that the pathogenicity of TPMV differs from that of HTNV in
humans.
In this study, we explored the integration of microarray
technology, qRT-PCR and target prediction and pathway enrich-
ment analyses. These studies allowed us to perform a robust
comparative bioinformatics study to reveal the host miRNA
molecular signatures associated with diverse hantavirus species.
We identiﬁed a unique pattern of cell type- and viral species-
speciﬁc host molecular responses and our data provide key
insights into miRNA expression patterns dynamically regulated
by HTNV vs. PHV infection. Although this study only observed
miRNA expression changes at day 3 post-infection, it will be
interesting to do temporal speciﬁc analysis of miRNA microar-
rays, since viral replication and resulting pathogenicity differ
between early (day 1 post-infection) vs. later (day 3–7 post-
infection) time points during infection (Handke et al., 2009; Shim
et al., 2011, Shin et al., 2012).
In conclusion, the expression proﬁles provide unique insights
into the miRNAs that are differentially expressed during infection
with hantaviruses of known and unknown pathogenicities. The
speciﬁc role of each of these miRNAs during hantavirus infection is
yet to be determined and is beyond the scope of the present study,
but our data suggest that the virus species-speciﬁc changes may
be another important determinant of hantavirus-associated
pathology. Our ﬁndings also raise the possibility of identifying, in
the very near future, circulating miRNA biomarkers to predict
clinical progression and/or disease severity in hantavirus-infected
patients.
Materials and methods
Cells and reagents
A549 cells (human epithelial lung cell, ATCC CCL-185) were
maintained in RPMI-1640 (Lonza) supplemented with 5% fetal
bovine serum (FBS), 2 mM L-glutamine and antibiotics (penicillin–
streptomycin) at 37 1C at 5% CO2. Induced pluripotent stem cell
HUVEC was purchased from Inopharmascreen (Asan, Korea) and
maintained in M199 (Gibco), containing penicillin–streptomycin,
25 mM HEPES, 10 unit/mL heparin, 2.2 g/L sodium bicarbonate,
20% FBS, basic ﬁbroblast growth factor (20 ng/mL) and passaged
up to seven times. The human monocytic cell line, THP-1, obtained
from the Korean Cell Line Bank (Seoul, Korea), was grown in RPMI-
1640 (Lonza) supplemented with 5% FBS, 2 mM L-glutamine and
antibiotics (penicillin–streptomycin) at 37 1C at 5% CO2. To induce
monocyte-to-macrophage differentiation, THP-1 cells were cul-
tured for 24 h in standard culture medium supplemented with
100 nM phorbol 12-myristate 13-acetate (PMA, Sigma-Aldrich).
Virus infection
TPMV (strain VRC 66412) (Carey et al., 1971), HTNV (strain 76–
118) (Lee et al., 2004), PHV (strain PHV-1) (Lee et al., 1985) and
MJNV strain 04–55 (Song et al., 2009) were propagated in Vero E6
Fig. 5. miRNA–mRNA association network for HTNV and PHV in HUVEC. miRNA–
mRNA interaction network between reliably differentially regulated miRNAs and
anti-viral and pro-inﬂammatory gene mRNAs [MxA, IFN-β, CXCL-10 (IP-10), CCL5
(RANTES)] in HUVEC between HTNV and PHV. Bars represent differential regula-
tion: green bar, down-regulated; pink, up-regulated; no bar, not changed. First bar,
HTNV; second bar, PHV.
Fig. 6. miRNA–mRNA associated network for HTNV in HUVEC, A549 and THP-1
cells. miRNA–mRNA interaction network between reliably differentially regulated
miRNAs and anti-viral and pro-inﬂammatory gene mRNAs in HTNV-infected
HUVEC and its comparison with (A) A549 cells and (B) THP-1 cells. Bars represent
differential regulation: green bar, down-regulated; pink, up-regulated; no bar, not
changed. First bar, HUVEC; second bar, A549 (in A) and THP-1 (in B).
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cells (Shim et al., 2011). A549, HUVEC and THP-1 cells were
infected at MOI of 0.5 for 90 min at 37 1C. After adsorption, the
cells were washed with phosphate buffered saline (PBS) and
maintained in complete medium.
MicroRNA microarray analysis
Total RNA was isolated followed by quality checks of both total
RNA and small RNA by using a 2100 Bioanalyzer and software that
detects 28 S and 18 S ribosomal RNA ratio, total RNA integrity
number, and small RNA and miRNA concentrations. miRNA
expression proﬁling was performed using the human microRNA
microarrays 860 K (V16) (Agilent Technologies, Inc). The micro-
array was designed based on Sanger miRBase (release 16.0) and
contained probes for 1205 human and 144 human viral miRNAs.
Hundred nanogram of total RNA was labeled using the Agilent
miRNA Complete Labeling and Hybridization Kit, according to the
manufacturer's instructions.
Quantitative real-time PCR
Quantitative real-time PCR (qRT-PCR) was used to
validate miRNA expression changes. Reverse transcription was
performed with GenoExplorer miRNA First-strand cDNA Core kit
(Genosensor), according to the manufacturer's instructions.
Reverse transcription was carried out in a volume of 20 μL with
1 μg of total RNA. Real-time PCR was performed in a StepOne Plus
machine (Applied Biosystems) using Power SYBR Green (Applied
Biosystems), according to the manufacturer's instructions, in a
total volume 15 μL. Cycling conditions for 4 target miRNA (hsa-
miR-494, hsa-miR-642b-3p, hsa-miR-151a-5p, hsa-miR-1973) and
U6 small RNA (internal control) were 10 min at 95 1C, 40 cycles of
15 s at 95 1C, and 30 s at optimal Tm (59 1C). Quantiﬁcation was
carried out with StepOne software v2.2.2 (Applied Biosystems).
Relative levels of target miRNAs were expressed as the ratio of
comparative threshold Cycle (Ct) to internal control small RNA.
Bioinformatics prediction of mRNA targets and gene ontology
A list of common gene targets from at least 5 prediction
databases (Tarbase, TargetScan, miRanda, microRNA.org and
microcosm) was obtained for each differentially expressed miRNA
and these target prediction softwares were used to predict the
target genes. To predict gene ontology (GO) and biological path-
ways associated with targets of selected miRNAs, the GO package
in R http://www.r-project.org/, canonical Kyoto Encyclopedia of
Genes and Genomes (KEGG) pathways maps and Panther protein
classiﬁcation tools, was used to annotate the functions of the
miRNA targets.
Ingenuity pathways analysis (IPA)
IPA (Ingenuity System Inc, USA) was used to determine miRNA-
mediated networks, biological functions and canonical signaling
pathways, functional signiﬁcance for the pathways targeted by
miRNAs. Biofunctions were grouped in: immune cell trafﬁcking,
cell-mediated immune response, and inﬂammatory response. In a
similar way canonical pathways were grouped in ERK/MAPK,
integrin, NF-kB, VEGF, JAK/STAT, role of pattern recognition recep-
tors in recognition of bacteria and viruses, role of RIG-I-like
receptors in anti-viral innate immunity, and interferon signaling
pathways.
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